Fabrazyme 35 mg powder for concentrate for solution for infusion
- Licence status
- Active substances
- Agalsidase Beta
- Dosage Form
- Powder for concentrate for solution for infusion
- Licence number
- EU/1/01/188/001-003
- Licence holder
- Sanofi B.V.
Product documents
Licence information
- ATC code
- A16AB04 agalsidase beta
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 17/06/2021